Kynam Capital Management, LP 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:01 pm Purchase | 2026-03-31 | 13G | SUTRO BIOPHARMA INC STRO | Kynam Capital Management, LP | 872,558 5.270% | 328,413 (+60.35%) | Filing |
| 2025-05-15 11:39 am Purchase | 2025-03-31 | 13G | SUTRO BIOPHARMA INC STRO | Kynam Capital Management, LP | 544,145 6.440% | 544,145 (New Position) | Filing |